Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My Cart

Main menu

  • Home
  • Articles
    • Archive
  • About the Journal
    • About CVI
    • For Librarians
    • For Advertisers
    • FAQ
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Clinical and Vaccine Immunology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Archive
  • About the Journal
    • About CVI
    • For Librarians
    • For Advertisers
    • FAQ
Diagnostic Laboratory Immunology

Monoclonal Antibody-Defined Specific C Epitope of Brucella O-Polysaccharide Revisited

Michel S. Zygmunt, David R. Bundle, N. Vijaya Ganesh, Julie Guiard, Axel Cloeckaert
D. L. Burns, Editor
Michel S. Zygmunt
aINRA, UMR1282 Infectiologie et Santé Publique, Nouzilly, France
bUniversité François Rabelais de Tours, UMR1282 Infectiologie et Santé Publique, Tours, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David R. Bundle
cDepartment of Chemistry, University of Alberta, Edmonton, Alberta, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N. Vijaya Ganesh
cDepartment of Chemistry, University of Alberta, Edmonton, Alberta, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julie Guiard
cDepartment of Chemistry, University of Alberta, Edmonton, Alberta, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Axel Cloeckaert
aINRA, UMR1282 Infectiologie et Santé Publique, Nouzilly, France
bUniversité François Rabelais de Tours, UMR1282 Infectiologie et Santé Publique, Tours, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. L. Burns
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/CVI.00225-15
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

The C epitope of Brucella O-polysaccharide (O-PS) has so far lacked definitive structural identity. Revised structures for this antigen revealed a unique capping perosamine tetrasaccharide consisting of a sequence of 1,2:1,3:1,2 interresidue linkages. Here, using synthetic oligosaccharide glycoconjugates, the α-1,3 linkage of the O-PS is shown to be an integral structural requirement of this epitope. Although A-dominant strains possess only one or two copies of the capping tetrasaccharide, this creates a unique pentasaccharide antigenic determinant with the linkage sequence 1,2:1,3:1,2:1,2 that is always present in major pathogenic Brucella species.

TEXT

Brucellae are Gram-negative, facultative, intracellular bacteria that can infect humans and many species of animals. The main animal- or human-pathogenic species of the genus Brucella, i.e., Brucella melitensis, Brucella suis, and Brucella abortus, carry a smooth (S) lipopolysaccharide (LPS) (S-LPS), a surface molecule that is a major virulence factor and the most important serodiagnostic antigen (1, 2). Its O-polysaccharide (O-PS) moiety represents the most exposed antigenic structure of the Brucella cell surface, and it carries the antigenic determinants involved in serotyping with polyclonal sera. At present, Brucella S strains are classified into three serotypes, i.e., A+M−, A−M+, and A+M+, according to slide agglutination with A and M monospecific polyclonal sera (3). Additionally, Brucella S strains share common epitopes on the O-PS with cross-reacting strains, of which the most important is Yersinia enterocolitica O:9 (1, 4, 5). By using monoclonal antibodies (MAbs), a number of epitope specificities on the O-PS have been reported: A, M, and epitopes shared by both A-dominant and M-dominant strains, which have been named common (C) epitopes (2, 5–12). The latter have been further subdivided according to relative preferential MAb binding in enzyme-linked immunosorbent assays (ELISA) into five epitopic specificities: C (M>A), C (A=M), C/Y (M>A), C/Y (A=M), and C/Y (A>M) (12). MAbs indicated with C are specific for Brucella, while those indicated with C/Y cross-react with Y. enterocolitica O:9. The preferential binding to A-dominant or M-dominant strains and equal binding to both strains are indicated by A>M or M>A and A=M, respectively.

The Brucella O-PS structure has been described as being constituted by homopolymers of 4,6-dideoxy-4-formamido-α-d-mannopyranose (N-formylperosamine) residues. In 1989, O-PS from A-dominant strains was reported as being a linear α-1,2-linked polymer, with about 2% α-1,3 linkages, while that from M-dominant strains constituted a linear polymer of pentasaccharide repeating units containing one α-1,3-linked and four α-1,2-linked monosaccharide residues (13). More recently, reinvestigation of the structure of Brucella O-antigens has defined the M epitope as a tetrasaccharide, missing one of the α-1,2-linked monosaccharide residues compared to the previously proposed structure (14), and this epitope always occurred as a capping element on the α-1,2-linked A-type polysaccharide. In addition, that study showed that M-dominant Brucella strain 16M contains several copies of the capping tetrasaccharide, thereby potentially creating additional unique sequences that are absent in those Brucella O-PSs with a single M capping tetrasaccharide. The differences between A-dominant and M-dominant strains were shown to be quantitative and depended on the length of α-1-2-linked polymer and the number of repeating M tetrasaccharides. In B. melitensis strain 16M, the α-1,2-linked chain was short, but the M-type polymer was long. In other strains, one or two M-type tetrasaccharides were present at the nonreducing end of the O-antigen.

Prior to the 2013 revision of the Brucella O-PS structure, MAbs specific for the C/Y epitopes were suggested to recognize α-1,2-linked tri- or tetrasaccharides of the O-PS (6). The α-1,3 linkage was suggested to be mainly involved in the structure recognized by MAbs specific for the M epitope, since such MAbs failed to react with Y. enterocolitica O:9, lacking the α-1,3 linkages, and their preferential binding to M-dominant O-PS correlated with an increased number of α-1,3-linked monosaccharide residues. However, in a more recent study, B. suis bv. 2 previously shown to lack the C epitope(s) (2) was also shown to lack α-1,3-linked monosaccharide residues in its O chain; it was thus suggested that the α-1,3 linkage would also be involved in the C epitope(s) MAb recognition. However, direct evidence for this has not been provided yet, and the role of the α-1,3 linkage in the recognition of the C epitope(s) remains questionable as, by definition, MAbs to such epitopes show equal binding to A-dominant, M-dominant or A+M+ Brucella strains, although they differ significantly in the levels of α-1,3 linkage expression in their O chain, from 2% to 20% (13). In light of the recent results of structural reinvestigation of the structure of Brucella O-antigens (14), in this study we reinvestigated the MAb specificities, in particular those previously defined as specific for the C and C/Y epitopes, using recently published synthetic oligosaccharide glycoconjugates (15, 16). These consisted of a series of nine oligosaccharides from di- to nonasaccharides, without or with α-1,3 linked N-formylperosamine situated in different locations within the oligosaccharide sequence.

Binding of the MAbs to these glycoconjugates was assessed by indirect ELISA using conditions previously published (2, 15, 16).

Results are shown in Table 1 and compared to binding data observed on whole bacterial cells of M-dominant B. melitensis strain 16M, A-dominant B. suis strain 1330, and A-dominant B. suis strain Thomsen (bv. 2) lacking the C epitope(s) (2). MAbs previously defined as specific for the M and C (M>A) epitopes did not bind at all to any oligosaccharide used in this study (Table 1). Comparatively, their binding titers on bacterial cells were also significantly lower than for the other MAbs. Their actual epitope specificity, thus, may be questionable. For those binding to the oligosaccharides, a first observation is that the minimal polymeric structure recognized by any of the MAbs is the pentasaccharide JG5 (Table 1). MAbs specific for the C/Y epitopes essentially recognize α-1,2-linked oligosaccharides, according to the high binding observed to NVG-220, consisting of an α-1,2-linked hexasaccharide without any α-1,3 linkage (Table 1). Both MAbs 12G12 and 07F09 specific for the C (A=M) epitope showed binding at high titers only to the penta-, hexa-, and nonasaccharides containing the α-1,3 linkage, i.e., JG5, NVG-224, and JG9, respectively (Table 1). These MAbs did not bind at all to the α-1,2-linked hexasaccharide NVG-220. Binding titers observed on the JG5, NVG-224, and JG9 oligosaccharides were identical regardless of the position of the α-1,3 linkage, indicating that the α-1,3 linkage is an essential feature in the recognition by the C (A=M)-specific MAbs. In agreement with this observation, a recent structural study on the O chain of B. suis bv. 2, which lacks this epitope (2), revealed the absence of the α-1,3-linkage in this particular O chain (17). The present study provides direct evidence that this Brucella-specific O chain linkage is essential to recognition by such antibodies.

View this table:
  • View inline
  • View popup
TABLE 1

Binding of the anti-O-PS MAbs in ELISA to Brucella strains and synthetic PSsa

Figure 1 summarizes the ELISA data in accordance with the oligosaccharide structures. From this figure, it becomes obvious that the C (A=M) epitope consists of a pentasaccharide where the α-1,3-linkage is exposed and located in the middle of the structure. However, it raises the question of why equal bindings, for MAbs recognizing this epitope, are observed on whole bacterial cells regardless of whether they are A dominant or M dominant, with the proportion of α-1,3 linkages of 2% and 20%, respectively. A possible explanation is that only the tip of the capped M epitope would be accessible and uniformly distributed on the bacterial surface from an antigenic point of view.

FIG 1
  • Open in new tab
  • Download powerpoint
FIG 1

Structural view of the C (A=M) and C/Y (A>M) epitopes. The C/Y (A>M) epitope is composed of ≥5 α-1,2-linked d-Rha4NFo residues (yellow circle). The C (A=M) epitope is composed of the disaccharide d-Rha4NFo (1,3) linked to α-1,2-linked d-Rha4NFo residues on each side (blue circle). All linkages are α-1,2 except the α-1,3 linkage indicated by the black arrows. +++, +, and − correspond to reactivity with MAbs.

FOOTNOTES

    • Received 15 April 2015.
    • Returned for modification 5 May 2015.
    • Accepted 2 June 2015.
    • Accepted manuscript posted online 10 June 2015.
  • Copyright © 2015, American Society for Microbiology. All Rights Reserved.

REFERENCES

  1. 1.↵
    1. Díaz-Aparicio E,
    2. Aragón V,
    3. Marín C,
    4. Alonso B,
    5. Font M,
    6. Moreno E,
    7. Pérez-Ortiz S,
    8. Blasco JM,
    9. Díaz R,
    10. Moriyón I
    . 1993. Comparative analysis of Brucella serotype A and M and Yersinia enterocolitica O:9 polysaccharides for serological diagnosis of brucellosis in cattle, sheep, and goats. J Clin Microbiol 31:3136–3141.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Cloeckaert A,
    2. Weynants V,
    3. Godfroid J,
    4. Verger JM,
    5. Grayon M,
    6. Zygmunt MS
    . 1998. O-polysaccharide epitopic heterogeneity at the surface of Brucella spp. studied by enzyme-linked immunosorbent assay and flow cytometry. Clin Diagn Lab Immunol 5:862–870.
    OpenUrlPubMed
  3. 3.↵
    1. Alton GG,
    2. Jones LM,
    3. Angus RD,
    4. Verger JM
    . 1988. Techniques for the brucellosis laboratory. Institut National de la Recherche Agronomique, Paris, France.
  4. 4.↵
    1. Bundle DR,
    2. Gidney MAJ,
    3. Perry MB,
    4. Duncan JR,
    5. Cherwonogrodzky JW
    . 1984. Serological confirmation of Brucella abortus and Yersinia enterocolitica O:9 antigens by monoclonal antibodies. Infect Immun 46:389–393.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Caroff M,
    2. Bundle DR,
    3. Perry MB
    . 1984. Structure of the O-chain of the phenol-phase soluble lipopolysaccharide of Yersinia enterocolitica serotype O:9. Eur J Biochem 139:195–200. doi:10.1111/j.1432-1033.1984.tb07994.x.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Bundle DR,
    2. Cherwonogrodzky JW,
    3. Gidney MAJ,
    4. Meikle PJ,
    5. Perry MB,
    6. Peters T
    . 1989. Definition of Brucella A and M epitopes by monoclonal typing reagents and synthetic oligosaccharides. Infect Immun 57:2829–2836.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Cloeckaert A,
    2. Jacques I,
    3. de Wergifosse P,
    4. Limet JN
    . 1992. Protection against Brucella melitensis or Brucella abortus in mice with immunoglobulin G (IgG), IgA, and IgM monoclonal antibodies specific for a common epitope shared by the Brucella A and M smooth lipopolysaccharides. Infect Immun 60:312–315.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Cloeckaert A,
    2. Zygmunt MS,
    3. Dubray G,
    4. Limet JN
    . 1993. Characterization of O-polysaccharide specific monoclonal antibodies derived from mice infected with the rough Brucella melitensis strain B115. J Gen Microbiol 139:1551–1556. doi:10.1099/00221287-139-7-1551.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Douglas JT,
    2. Palmer DA
    . 1988. Use of monoclonal antibodies to identify the distribution of A and M epitopes on smooth Brucella species. J Clin Microbiol 26:1353–1356.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Palmer DA,
    2. Douglas JT
    . 1989. Analysis of Brucella lipopolysaccharide with specific and cross-reacting monoclonal antibodies. J Clin Microbiol 27:2331–2337.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Vizcaino N,
    2. Chordi A,
    3. Fernández-Lago L
    . 1991. Characterization of smooth Brucella lipopolysaccharides and polysaccharides by monoclonal antibodies. Res Microbiol 142:971–978. doi:10.1016/0923-2508(91)90007-W.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    1. Weynants V,
    2. Gilson D,
    3. Cloeckaert A,
    4. Tibor A,
    5. Denoel PA,
    6. Godfroid F,
    7. Limet JN,
    8. Letesson JJ
    . 1997. Characterization of smooth lipopolysaccharide and O polysaccharides of Brucella species by competition binding assays with monoclonal antibodies. Infect Immun 65:1939–1943.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Meikle PJ,
    2. Perry MB,
    3. Cherwonogrodzky JW,
    4. Bundle DR
    . 1989. Fine structure of A and M antigens from Brucella biovars. Infect Immun 57:2820–2828.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Kubler-Kielb J,
    2. Vinogradov E
    . 2013. Reinvestigation of the structure of Brucella O-antigens. Carbohydr Res 378:144–147. doi:10.1016/j.carres.2013.03.021.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Ganesh NV,
    2. Sadowska JM,
    3. Sarkar S,
    4. Howells L,
    5. McGiven J,
    6. Bundle DR
    . 2014. Molecular recognition of Brucella A and M antigens dissected by synthetic oligosaccharide glycoconjugates leads to a disaccharide diagnostic for brucellosis. J Am Chem Soc 136:16260–16269. doi:10.1021/ja5081184.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. McGiven J,
    2. Howells L,
    3. Duncombe L,
    4. Stack J,
    5. Ganesh NV,
    6. Guiard J,
    7. Bundle DR
    . 2015. Improved serodiagnosis of bovine brucellosis by novel synthetic oligosaccharide antigens representing the capping M epitope elements of Brucella O-polysaccharide. J Clin Microbiol 53:1204–1210. doi:10.1128/JCM.03185-14.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Zaccheus MV,
    2. Ali T,
    3. Cloeckaert A,
    4. Zygmunt MS,
    5. Weintraub A,
    6. Iriarte M,
    7. Moriyón I,
    8. Widmalm G
    . 2013. The epitopic and structural characterization of Brucella suis biovar 2 O-polysaccharide demonstrates the existence of a new M-negative C-negative smooth Brucella serovar. PLoS One 8:e53941. doi:10.1371/journal.pone.0053941.
    OpenUrlCrossRefPubMed
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Monoclonal Antibody-Defined Specific C Epitope of Brucella O-Polysaccharide Revisited
Michel S. Zygmunt, David R. Bundle, N. Vijaya Ganesh, Julie Guiard, Axel Cloeckaert
Clinical and Vaccine Immunology Jul 2015, 22 (8) 979-982; DOI: 10.1128/CVI.00225-15

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Email

Thank you for sharing this Clinical and Vaccine Immunology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Monoclonal Antibody-Defined Specific C Epitope of Brucella O-Polysaccharide Revisited
(Your Name) has forwarded a page to you from Clinical and Vaccine Immunology
(Your Name) thought you would be interested in this article in Clinical and Vaccine Immunology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Monoclonal Antibody-Defined Specific C Epitope of Brucella O-Polysaccharide Revisited
Michel S. Zygmunt, David R. Bundle, N. Vijaya Ganesh, Julie Guiard, Axel Cloeckaert
Clinical and Vaccine Immunology Jul 2015, 22 (8) 979-982; DOI: 10.1128/CVI.00225-15
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • TEXT
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About CVI
  • For Librarians
  • For Advertisers
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • Submit a Manuscript to mSphere

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 1556-6811; Online ISSN: 1556-679X